Skip to main content

Main menu

  • Home
  • Articles
    • Current Issue
    • Next in The JI
    • Archive
    • Brief Reviews
      • Neuroimmunology: To Sense and Protect
    • Pillars of Immunology
    • Translating Immunology
    • Most Read
    • Top Downloads
    • Annual Meeting Abstracts
  • COVID-19/SARS/MERS Articles
  • Info
    • About the Journal
    • For Authors
    • Journal Policies
    • Influence Statement
    • For Advertisers
  • Editors
  • Submit
    • Submit a Manuscript
    • Instructions for Authors
    • Journal Policies
  • Subscribe
    • Journal Subscriptions
    • Email Alerts
    • RSS Feeds
    • ImmunoCasts
  • More
    • Most Read
    • Most Cited
    • ImmunoCasts
    • AAI Disclaimer
    • Feedback
    • Help
    • Accessibility Statement
  • Other Publications
    • American Association of Immunologists
    • ImmunoHorizons

User menu

  • Subscribe
  • Log in

Search

  • Advanced search
The Journal of Immunology
  • Other Publications
    • American Association of Immunologists
    • ImmunoHorizons
  • Subscribe
  • Log in
The Journal of Immunology

Advanced Search

  • Home
  • Articles
    • Current Issue
    • Next in The JI
    • Archive
    • Brief Reviews
    • Pillars of Immunology
    • Translating Immunology
    • Most Read
    • Top Downloads
    • Annual Meeting Abstracts
  • COVID-19/SARS/MERS Articles
  • Info
    • About the Journal
    • For Authors
    • Journal Policies
    • Influence Statement
    • For Advertisers
  • Editors
  • Submit
    • Submit a Manuscript
    • Instructions for Authors
    • Journal Policies
  • Subscribe
    • Journal Subscriptions
    • Email Alerts
    • RSS Feeds
    • ImmunoCasts
  • More
    • Most Read
    • Most Cited
    • ImmunoCasts
    • AAI Disclaimer
    • Feedback
    • Help
    • Accessibility Statement
  • Follow The Journal of Immunology on Twitter
  • Follow The Journal of Immunology on RSS

Decreased E12 and/or E47 Transcription Factor Activity in the Bone Marrow As Well As in the Spleen of Aged Mice

Daniela Frasca, Diep Nguyen, Richard L. Riley and Bonnie B. Blomberg
J Immunol January 15, 2003, 170 (2) 719-726; DOI: https://doi.org/10.4049/jimmunol.170.2.719
Daniela Frasca
Department of Microbiology and Immunology, University of Miami School of Medicine, Miami, FL 33136.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Diep Nguyen
Department of Microbiology and Immunology, University of Miami School of Medicine, Miami, FL 33136.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Richard L. Riley
Department of Microbiology and Immunology, University of Miami School of Medicine, Miami, FL 33136.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Bonnie B. Blomberg
Department of Microbiology and Immunology, University of Miami School of Medicine, Miami, FL 33136.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Figures & Data
  • Info & Metrics
  • PDF
Loading

Abstract

The E2A-encoded transcription factors E12 and E47 are key regulators of B cell functions. They bind to the E-box site, found in regulatory regions of B cell-specific genes; promote cell survival of early pre-B cells; help to initiate Ig rearrangements; and are also involved in class switch in mature B cells in the periphery. We have investigated the expression and function of E47 and E12 in IL-7-expanded pro-B/pre-B cell precursors and in unstimulated or LPS-activated splenic B cells from young and old BALB/c mice. Results show that B cell precursors from the bone marrow of old mice exhibit a reduced expression of E2A proteins and a reduced ability to bind DNA, as compared with young mice. In the spleen, E2A protein expression and DNA binding are present in unstimulated B cells from young mice and, to a significantly lesser extent, from old mice. These are both strongly induced by activation in splenic B cells from young mice but only moderately induced in old mice, indicating that aging affects the expression and activity of E2A-encoded genes and also that DNA binding correlates with the amount of protein expression. The levels of E2A DNA binding in the spleen correlate with those in the bone marrow for individual mice. In splenic mature B cells, only E47/E47 complexes bind DNA; whereas in bone marrow B cell precursors, E47/E12 complexes participate in DNA binding. Only nuclear extracts of splenic mature B cells, but both nuclear and cytoplasmic extracts of bone marrow B cell precursors, exhibit DNA binding.

The E2A gene encodes two class I basic helix-loop-helix (bHLH)3 proteins, E12 and E47, which are RNA splice variants. E12 and E47 are multifunctional transcription factors involved in a large variety of developmental processes, characterized by their broad tissue distribution and by their ability to form homodimers or heterodimers with tissue-restricted class II bHLH. The two proteins share identical N-terminal trans activation domains but have distinct dimerization and DNA-binding motifs (1, 2, 3, 4).

E47 was first identified as a protein that binds Ig and insulin gene-regulatory elements (2, 5, 6). In B lymphocytes, the active DNA-binding complex consists of E47 homodimers (7, 8, 9); whereas in non-B cells, E47 is unable to bind DNA or it binds DNA as a heterodimer with cell-restricted bHLH proteins, such as MyoD or NeuroD (10, 11). The formation and function of the homodimer or heterodimer depend on the balance between the E2A-encoded proteins, other class I bHLH proteins (class I bHLH transcription factor and E2-2), and the E protein-inhibitory proteins, Id 1–3, which lack the DNA-binding domain and function as dominant negative inhibitors of E proteins (12). E2A-null mutant mice fail to generate precursors and mature B cells. The arrest of B cell development occurs at an early stage, given that no Ig DJ rearrangements or expression of the B lineage-specific marker B220 can be detected in homozygous mutant mice (13, 14). Reconstitution of normal numbers of peripheral mature B cells requires the presence of both E12 and E47 (15). E2A transcription factors have been shown to regulate the expression of several B lineage genes such as λ5, early B cell factor, TdT, and recombination-activating gene-1 (15, 16, 17, 18, 19), to regulate Ig rearrangements (20, 21), and to promote Ig class switch recombination (2).

Aging is associated with decreased production of precursor B lineage cells in the bone marrow (22, 23, 24, 25, 26, 27). However, despite the decrease in newly emerging cells from the bone marrow, the population of mature splenic B cells is maintained because of increased life span (23, 28). Reduced diversification of B cells has also been reported to occur in the germinal center (29), where affinity maturation and isotype switching take place (30, 31, 32). We have previously demonstrated that pre-B cell numbers, as well as the surrogate L chain, composed of the variable-like region of the pre-B cell receptor (VpreB) and λ5 peptides, which is critical for Ig variable heavy chain selection, cellular proliferation, and survival at the pre-B cell stage, are significantly reduced in aged mice (22, 26, 33). We further showed that low surrogate L chain mRNA and protein levels, as measured in IL-7-expanded cultures of B cell precursors from aged mice, are associated with decreased protein levels of the E2A-encoded transcription factors E47 and E12 (26).

Here, we have investigated the expression and function of the E2A-encoded transcription factors E12 and E47 in IL-7-expanded pro-B/pre-B cell precursors and in splenic B cells, unactivated or LPS activated, from aging mice. We examined whether the decrease seen in E2A protein levels in aged bone marrow could also be reflected in functional DNA binding and if these measurements of E2A (E12/E47) would also be affected in splenic B cells from aged mice. Moreover, we investigated the nature of the complex, i.e., whether E12/E47 or E47/E47 dimers were involved in DNA binding in B cell precursors in the bone marrow and in mature B cells in the spleen.

Materials and Methods

Mice

Male and female young (2–4 mo of age) and old (24–27 mo of age) BALB/c mice were obtained from the National Institute on Aging (Bethesda, MD).

Splenic B cell purification

B cells were isolated from the spleens of young and old mice. Briefly, cells were washed twice with medium (RPMI 1640; Life Technologies, Gaithersburg, MD) and incubated (108 cells/ml) for 20 min at 4°C with 100 μl of anti-B220 Microbeads (Miltenyi Biotech, Bergisch Gladbach, Germany), according to the MiniMacs protocol (Miltenyi). Cells were then purified using magnetic columns. At the end of the purification procedure, cells were found to be almost exclusively (85–90%) B220 positive by cytofluorimetric analysis. After the isolation procedure was ended, cells were maintained in serum-free medium for 3 h at 4°C to minimize potential effects of anti-B220 Abs on B cell activation.

B cell culture

B cells were cultured in complete medium (RPMI 1640, supplemented with 10% FCS, 10 μg/ml penicillin-streptomycin and 2 mM l-glutamine). For the determination of the optimal culture conditions, cells (2 × 104 or 2 × 105 in 200 μl of complete medium) were stimulated for 24, 48, or 72 h in 96-well culture plates with LPS (0.1, 1 or 10 μg/ml; Sigma-Aldrich, St. Louis, MO). In the last 4 h of incubation, cultures were pulsed with 1 μCi of [3H]thymidine to determine cell proliferation. Our previous results (34) indicate that optimal B cell proliferation is induced when 1 × 106 cells/ml in a final volume of 200 μl are activated by 10 μg/ml LPS for 48 h. Doses of 0.5 and 2 × 106 cells/ml in a final volume of 200 μl were also evaluated but yielded lower B cell proliferation than did the dose of 1 × 106 cells/ml. For the preparation of nuclear and cytoplasmic extracts, B cells (1 × 106/ml) were stimulated for 48 h in six-well culture plates with 10 μg/ml LPS. These conditions were optimal for cell proliferation. After this time, cells were lysed, and extracts were prepared.

Bone marrow cell culture and Ab staining

Bone marrow cells (3 × 105) from 28 pairs of young and old mice were analyzed for surface CD43, B220, and IgM. Briefly, cells were incubated with PE-labeled anti-CD43 Abs (1/40 diluted; BD PharMingen, San Diego, CA), CY-conjugated anti-B220-Abs (1/40 diluted; BD PharMingen), and FITC-labeled anti-μ Abs (1/100 diluted; Jackson ImmunoResearch Laboratories, West Grove, PA) in FACS buffer (HBSS, buffered in 0.02% sodium azide and 0.1% BSA) for 30 min on ice, using the protocol described elsewhere (26). After staining, cells were fixed with 0.25% paraformaldehyde. Samples of 104 cells were analyzed on a LSR flow cytometer (BD PharMingen) using a logarithmic amplification. The percentage of pre-B cells (IgM−CD43−B220low) from total nucleated bone marrow cells was significantly decreased by aging in 23 of 28 mice, similar to previous results (26, 33). Thus, old mice were classified as severely depleted mice (>80% loss in pre-B cells) or moderately depleted mice (20–80% loss in pre-B cells). Of 28 mice, 5 were nondepleted. Table I⇓ summarizes the results obtained with these mice. Expanded populations of pro-B/pre-B cells from young and old mice were obtained as previously described (26, 27). Briefly, bone marrow cells were cultured in six-well culture plates at the concentration of 106/ml in complete medium in the presence of 5 ng/ml murine IL-7 (BioSource International, Camarillo, CA). Seven days later, nonadherent cells were harvested, analyzed by flow cytometry, and lysed; nuclear and cytoplasmic extracts were prepared. The expansion of pro-B/early pre-B cells with IL-7 was decreased significantly in the bone marrow from old as compared with young mice beginning at day 3 after culture initiation and continuing through day 7. At day 7, we observed the maximum difference in expansion between young and old mice (26). After day 7, a great proportion of dead cells were found in both young and old mice.

View this table:
  • View inline
  • View popup
Table I.

Effect of aging on the percentage of pre-B cells (IgM−CD43−B220low) from total nucleated bone marrow cellsa

Preparation of nuclear and cytoplasmic extracts and total cell lysates

Nuclear and cytoplasmic extracts were prepared from cultured bone marrow or spleen cells essentially as previously published (35); briefly, cells were harvested and centrifuged in an Eppendorf 5415C microfuge (Brinkmann Instruments, Westbury, NY; New York; 2000 rpm, 5 min). The pellet was resuspended in 30 μl of solution A containing 10 mM HEPES (pH 7.9), 10 mM KCl, 1.0 mM EDTA, 1 mM DTT, 1.5 mM MgCl2, 1 mM PMSF, 1 tablet of protease inhibitor mixture (Boehringer Mannheim, Mannheim, Germany), and Nonidet P-40 (0.1%); briefly vortexed; and centrifuged (8000 rpm, 5 min, 4°C). The supernatant containing the cytoplasmic extract was removed, and the pellet containing the nuclei was resuspended in solution B containing 20 mM HEPES (pH 7.9), 0.1 mM EDTA, 1 mM DTT, 1.5 mM MgCl2, 2 mM PMSF, 1 tablet of protease inhibitor mixture, and glycerol (10%). The lysate was incubated on ice for 20 min, protein sonicated for a few seconds, and centrifuged (14,000 rpm, 15 min, 4°C). Aliquots of the nuclear extract were stored at −80°C. For the preparation of total cell lysates, cultured cells were harvested and centrifuged in an Eppendorf 5415C microfuge (2000 rpm, 5 min). The pellet was resuspended in 30 μl of a solution containing 50 mM Tris-HCl (pH 7.5), 150 mM NaCl, 0.1% Nonidet P-40, 0.5% sodium deoxycholate, 1 tablet of protease inhibitor mixture (Boehringer Mannheim), and 1 mM PMSF; briefly vortexed; and centrifuged (14,000 rpm, 15 min, 4°C). Protein content was determined by the Bradford assay.

Preparation of the DNA probes

The μE5 probe was prepared as follows: 100 μl of each single strand (26 bp), at a concentration of 100 ng/μl, were annealed volume for volume at temperatures of 85°C (2 min), 65°C (15 min), 37°C (15 min), and 25°C (15 min) and on ice (15 min) and then end labeled for 40 min at 37°C, using T4 DNA polynucleotide kinase in the presence of 1 μl of [γ-32P]ATP. The probe was then purified over a Sepharose G-25-50 column (Sigma-Aldrich). The ku probe was prepared as follows. A double strand ku DNA fragment (56 bp), 10 pmol of the 56-oligomer, was end labeled for 30 min at 37°C with T4 DNA polynucleotide kinase in the presence of 2 μl of [γ-32P]ATP, then incubated with 20 pmol of the complementary oligonucleotide at 85°C for 5 min, and subsequently cooled at room temperature. The probe was then purified over a Sepharose G-50-80 spin column (Sigma-Aldrich). The sequences of the probes were: 5′-CCC-GGC-GCGGGG-GCG-ATT-TCG-AGT-CA-3′ (μE5, present in the IgH intronic enhancer) (36) and 5′-GAT-CAG-TGA-TGG-AGT-TGG-CCA-CTC-CCTCTC-TGC-GCG-CTC-GCT-CGC-TCA-CTG-AGG-CC-3′ (ku). The 56-oligomer sequence was constructed by modifying the sequence originally described (37) to obtain optimal ku binding to DNA, as heterodimer ku 70/80 (38).

EMSA

A gel mobility shift assay to determine DNA binding of E47 and of ku was performed as follows. The radiolabeled DNA probe was incubated with 10 μg of nuclear extract in the presence of 0.5 μg of poly(dI-dC) or of the circular plasmid pUC9 as nonspecific competitors for μE5 and ku, respectively. The reaction was performed at room temperature in 15 μl of binding buffer (10 mM Tris-HCl (pH 7.5), 75 mM NaCl, 1 mM DTT, 1 mM PMSF, 6% glycerol). To supershift E47 and/or E12, the nuclear extracts were preincubated with rabbit anti-mouse polyclonal E47 (2 μl; Santa Cruz Biotechnology, Santa Cruz, CA), rabbit anti-mouse polyclonal E12 (2 μl; Santa Cruz Biotechnology) Abs, before the addition of the radiolabeled probes. These Abs were the best supershifting Abs, compared with other anti-E47/anti-E12 Abs (BD PharMingen), based on the evidence that they completely prevented the binding of the μE5 complexes in IL-7-expanded pro-B/pre-B cells, similar to the anti-E47 and anti-E12 mAbs of BD-PharMingen, but could be used at a concentration of 50-fold less protein concentration (4-fold less supplied concentration). To supershift the ku 70/80 heterodimers, the nuclear extracts were preincubated with the polyclonal anti-ku 80 (2 μl; Serotec, Oxford, U.K.), before the addition of the radiolabeled probes. The samples were electrophoresed in 5% polyacrylamide gel at 175 V for 3 h at room temperature. The gels were dried on Whatman 3M paper and exposed to Kodak x-ray films (Eastman, Rochester, NY) at −80°C overnight.

Western blotting

For the evaluation of the amounts of E47 and ku 80 proteins in the cytoplasm and in the nucleus of splenic B cells, cytoplasmic and nuclear extracts at equal protein concentration were denatured by boiling for 4 min in Laemmli sample buffer and subjected to SDS-PAGE using 4–12% polyacrylamide gel under reducing conditions. Proteins were then electrotransferred onto nitrocellulose filters (Bio-Rad, Hercules, CA). Nonspecific sites were blocked by incubation of the membranes with PBS-Tween (1× PBS containing 0.05% Tween 20) containing 5% milk for 1 h at room temperature (blocking solution). Filters were incubated with mouse monoclonal anti-E47 Abs (1/400 diluted, BD PharMingen), mouse monoclonal anti-E12 Abs (1/400 diluted, BD PharMingen), rabbit polyclonal anti-ku 80 Abs (1/500 diluted; Serotec), goat polyclonal anti-Ikaros Abs (1/200 diluted; Santa Cruz Biotechnology), or hamster monoclonal FS1 anti-λ5 Ab (1/5 diluted; gift from Dr. J. Jongstra). These anti-E47 and anti-E12 Abs gave the best signal by Western analyses. Mouse monoclonal anti-β-actin (1/8000 diluted; Sigma-Aldrich) and mouse monoclonal anti-histone H-1 (1/200 diluted; Santa Cruz Biotechnology) were used to detect β-actin and histone H-1, respectively, as loading controls. After overnight incubation with the primary Ab, immunoblots were incubated with the appropriate HRP-labeled secondary Abs (Rockland, Gilbertsville, PA; 1/16,000 diluted, for mouse primary Abs; Santa Cruz Biotechnologies, 1/200 diluted, for rabbit primary Abs; Santa Cruz Biotechnology 1/200 diluted, for goat primary Abs) for 3 h at 4°C, developed by enzyme chemiluminescence, and exposed to CL-XPosure Film (Pierce, Rockford, IL).

Results

Cultures of splenic B cells from young and old mice, unstimulated or stimulated with LPS, and cultures of bone marrow cells from the same young and old mice, stimulated in culture with IL-7 during a period of 7 days, were set up in parallel to minimize the variations between independent experiments.

DNA binding of E12 and/or E47 are decreased in both bone marrow and spleen of aged mice

Nuclear extracts of whole bone marrow cells from young and old mice, as well as of pro-B/pre-B cells from young and old mice, in vitro expanded with IL-7 for 7 days, were prepared and analyzed by EMSA, using the μE5 sequence as probe. Results were obtained at day 7 because it is very difficult to measure the levels of E2A in IL-7 cultures, at least before day 6, because the small number of cells recovered is not sufficient to allow Western analyses. In addition, the ratios of pro-B vs pre-B cells change during culture, pro-B and pre-B cells express different levels of E2A (12), and therefore cultured cells would have to be sorted before analysis. Results in Fig. 1⇓A show that the sensitivity of our EMSA analysis can measure DNA binding only in nuclear extracts from IL-7-stimulated pro-B/pre-B cells, but not from whole bone marrow cells. Typically, IL-7-stimulated bone marrow results in about a 10× expansion of precursor cells, which gives pro-B cells (∼80%) and early pre-B cells (∼20%) (26). We have previously shown a reduction in pro-B/pre-B cells of old bone marrow cells expanded on IL-7 culture as compared with young bone marrow (26, 33) and a decreased protein level of E12/E47 in old IL-7 blasts (26). Here we show that IL-7-stimulated pro-B/pre-B cells from old mice exhibit a significantly reduced ability to bind the μE5 sequence compared with young mice (Fig. 1⇓A). Both E12 and E47 are in the DNA-binding complex in these expanded pro-B/pre-B cells, as indicated by the use of anti-E12 and anti-E47 Abs in the supershift in Fig. 1⇓A.

FIGURE 1.
  • Download figure
  • Open in new tab
  • Download powerpoint
FIGURE 1.

E47/E12 DNA binding is decreased in old bone marrow (BM) precursor B cells and splenic B cells. A, IL-7 blasts from young (Y) but not from old (O) bone marrow show high levels of E12/E47 DNA binding. Untreated young bone marrow cells also do not show activity. Nuclear extracts from the same numbers (107) of whole bone marrow cells or IL-7-expanded pro-B/pre-B cells were run in EMSA (10 μg/lane). EMSA with whole bone marrow cells has been repeated twice, whereas EMSA with IL-7 blasts has been repeated eight times, in all cases giving comparable results. NS, nonspecific bands. Anti-(α)-E47, anti-E12, supershift, described in Materials and Methods. B, E47 DNA binding is up-regulated in splenic B cells from young and, to a significantly lesser extent, old mice. Splenic B cells (106 cells/ml) from one young and one old mouse were left unstimulated or were stimulated with 10 μg/ml LPS for 24, 48, and 72 h. Nuclear extracts from the same numbers of cultured B cells were prepared and run in EMSA (10 μg/lane). E47/E47 complexes can form single (B) or multiple (A) protein-DNA complexes, the number of which depends on the concentration of the transcription factor in the nuclear extract. Films were scanned and analyzed using Scion Image for Windows (Scion, Frederick, MD). Integrated areas under the densitometric curves for each band were used as estimates of DNA binding. Vertical columns represent the fold increase ± SE in E47 DNA binding as compared with those of young, unstimulated controls, taken as 1. Results are the means of the densitometric estimates ± SE from four young and four old mice independently evaluated. Young values were: 1 (unstimulated); 5.3 ± 2.1 (24 h); 8.1 ± 2.4 (48 h); and 4.3 ± 2.8 (72 h). Old values were: 0.6 ± 0.1 (unstimulated); 2.3 ± 0.9 (24 h); 3.43 ± 1.6 (48 h); and 1.8 ± 0.7 (72 h). At 48 h of stimulation, the activation is maximal for young and old cells, and the difference between young and old mice is significant at p < 0.05, as determined by the two-tailed Student t test. □, Young; ▪, old. C, E2A DNA binding in IL-7 blasts and LPS-activated splenic B cells is equivalently reduced in the same aged individual mice. Nuclear extracts from equal numbers (107) of IL-7-expanded pro-B/pre-B cells or splenic B cells stimulated with LPS for 48 h were run in EMSA (10 μg/lane). Films were scanned and analyzed as described in B. In IL-7 blasts, the levels of DNA binding of old vs young were 1–13% in seven of eight mice, with the exception that in one pair of mice (pair 4), old DNA binding was 83% of young controls. This mouse was the only one not to be depleted in pre-B cells (with 11.5% pre-B cells) as evaluated by flow cytometry. In LPS-activated splenic B cells, the levels of old DNA binding were 2–40% compared with young controls in seven of eight mice; and similar to IL-7 blasts, in pair 4, DNA binding was 81% of young controls. D, DNA binding of ku 70/80 is not modified by B cell activation or by aging. The same nuclear extracts shown in B were run in EMSA (10 μg/lane) using a 56-oligonucleotide probe that binds the DNA repair enzyme ku 70/80. The multiple bands are created by one, two, or more multimers of ku binding to DNA. S, Supershift performed with the anti-ku 80 Ab (see Materials and Methods).

To determine the kinetics of E47 DNA-binding in mitogen-activated splenic B cells from young or old mice, nuclear extracts from splenic B cells (1 × 106/ml), activated with 10 μg/ml LPS for 24, 48, or 72 h, were prepared and analyzed by EMSA, using the μE5 probe. Results in Fig. 1⇑B show measurable, although low, E47 DNA binding in unstimulated splenic B cells from young mice. Activation of B cells from young mice with LPS up-regulates E47 DNA binding at all times of stimulation, with the highest level of E47 activation attained after 48 h in the presence of LPS. In old mice, the endogenous E47 DNA binding is lower than that in unstimulated young spleen cells in 13 of 20 (65%) mice individually tested. Additionally, activation of B cells from old mice with LPS induces a lower increase in E47 DNA binding, as compared with that seen in young mice, the fold increase (relative to unstimulated young) in young vs old being 5 vs 2 at 24 h, 8 vs 3 at 48 h, and 4 vs 2 at 72 h. Thus, in old mice also, the highest level of E47 activation was reached after 48 h in the presence of LPS. At 0 time points (endogenous), all of four old mice had lower amounts of E47 DNA binding. The stimulated values (e.g., at 48 h) were lower (also when the stimulation index was calculated compared with the age-matched 0 time point control) for two of four old mice. Therefore, the fold increase of old stimulated mice, relative to unstimulated old, is 3.8 at 24 h, 5.7 at 48 h, and 3.0 at 72 h. Moreover, in other cultures set up for 48 h only, in 7 of 20 old mice (35%) in which the endogenous E47 DNA binding was comparable with that of young mice, the LPS-induced E47 DNA binding was also increased over that of the unstimulated controls, but still lower than that in young mice. These results of lower endogenous E47 DNA binding in aged splenic B cells (2- to 4-fold) have been reproduced in many other experiments. Additionally, the fold stimulation seen at peak times of stimulation (i.e., 48 h with anti-CD40 and IL-4) has also been shown to be always lower in aged vs young splenic B cells (2- to 4-fold) (Ref. 34 and our unpublished results).

Results in Fig. 1⇑C, showing 8 of 20 pairs of mice in this study, indicate a comparable age-related reduction in the ability of nuclear extracts from both IL-7 blasts and LPS-stimulated splenic B cells from the same old mice to bind the μE5 sequence. Even if the age of the mice is toward the end of BALB/c life expectancy (up to 30 mo), we still see in that range of ages old mice that are not depleted in pre-B cells (Fig. 1⇑C, pair 4, where the old mouse is 25 mo old). We do not know when the reduction of E2A-encoded factors is first observed. However, we were able to see decrease in E2A-binding activity in 18-mo-old mice (data not included). From the data published elsewhere (26), altered expression of E2A in old mice is completely correlated with reduction of surrogate light chains observed in in vitro expanded pro-B/early pre-B cells. This in turn contributes to the decreased B lymphopoiesis; therefore, we can expect that the decline in E2A expression likely precedes that of pre-B cell depletion. When the same nuclear extracts were analyzed by EMSA with a 56-oligonucleotide probe, previously described to bind the DNA repair enzyme ku 70/80, no effects of aging or even of LPS stimulation were observed (Fig. 1⇑D). This is consistent with previous reports that ku 70/80 is unaffected during aging in human PBMC (38).

The DNA-binding complex is different in B cell precursors and in mature splenic B cells

We then examined the presence of E47 and/or E12 in the DNA-binding complexes in splenic B cells from young and old mice. Results in Fig. 2⇓ show that in both young and old mice, anti-E47 Abs effectively prevent DNA binding from splenic nuclear extracts, whereas anti-E12 Abs do not modify the DNA binding in the complex, confirming previous reports that only E47/E47 complexes bind DNA in mature B cells (2). Interestingly, and in contrast to splenic B cells, either anti-E47 or anti-E12 Abs were able to completely supershift the band due to DNA binding of E12/E47 proteins in IL-7-blasts, suggesting that the composition of E complexes able to bind DNA differs in B cell precursors (Fig. 1⇑A) as compared with mature B cells. Specificity was shown by the ku probe not being shifted/removed by anti-E47 Abs and by anti-class I bHLH transcription factor Abs not preventing the binding to the μE5 probe (data not shown).

FIGURE 2.
  • Download figure
  • Open in new tab
  • Download powerpoint
FIGURE 2.

Only E47/E47 complexes bind DNA in splenic B cells. Splenic B cells (106 cells/ml) were left unstimulated or they were stimulated with 10 μg/ml LPS for 48 h. Nuclear extracts from same numbers of unstimulated and LPS-activated B cells were prepared and run in EMSA (10 μg/lane), in the presence or absence of anti-E47 and anti-E12 Abs. This experiment has been repeated five times, giving comparable results.

E47 expression is up-regulated by B cell activation

The expression of the E2A-encoded proteins by Western blot in total cell lysates from IL-7-expanded pro-B/pre-B cells shows that the levels of E47 and E12 proteins are decreased in old pro-B/pre-B extracts (Fig. 3⇓A). Western analysis was also performed for Ikaros and mouse λ5 proteins. Results show that Ikaros is present at comparable levels in IL-7-expanded pro-B/pre-B cells from young and old mice. Mouse λ5, as already demonstrated previously (26), is decreased by aging, although in this sample to a lesser degree than normally seen in aged pro-B/pre-B cells.

FIGURE 3.
  • Download figure
  • Open in new tab
  • Download powerpoint
FIGURE 3.

E47/E12, but not other proteins, are down-regulated in IL-7-expanded pro-B/pre-B cells and LPS-activated splenic B cells by Western blot analysis. A, Total lysates from IL-7-expanded bone marrow pro-B/pre-B cells (106 cells/ml) from young and old mice were prepared and run in Western blot. The titration is 2, 4, and 8 μg of cell lysate/lane. E47, E12, Ikaros, λ5, and β-actin were detected with specific Abs. B, LPS-activated splenic B cells from old mice show reduced E47 expression, but normal ku 80 expression, compared with young mice. Splenic B cells (106 cells/ml) were left unstimulated or they were stimulated with 10 μg/ml LPS for 24, 48, and 72 h. Nuclear extracts from equal numbers of unstimulated and LPS-activated B cells were prepared and run in Western blot (8 μg/lane). E47, ku 80, and histone H-1 were detected with specific Abs. Films were scanned and analyzed as described in Fig. 1⇑B. Vertical columns represent the fold increase ± SE in E47 DNA binding compared with those of young, unstimulated controls, taken as 1. Results are the means of the densitometric estimates ± SE from two young and two old mice independently evaluated. Young values were: 1 (unstimulated); 1.5 ± 0.2 (24 h); 4.3 ± 0.3 (48 h); and 0.6 ± 0.3 (72 h). Old values were: 0.5 ± 0.04 (unstimulated); 1.4 ± 1.0 (24 h); 1.7 ± 0.3 (48 h); and 1.3 ± 1.0 (72 h). At 48 h of stimulation, the difference between young and old mice was significant at p < 0.05, as determined by the two-tailed Student t test. □, Young; ▪, old.

Because DNA binding of E47 is up-regulated in splenic B cells from young and, to a lesser extent, from old mice by LPS, we examined the levels of E47 protein by Western blotting in nuclear extracts of activated splenic B cells from young and old mice. Results in Fig. 3⇑B show that E47 protein is present in the nuclear extracts of unstimulated splenic B cells from young mice. The amount of E47 increases after 24 and 48 h and decreases after 72 h of stimulation in the presence of LPS. In the nuclear extracts of unstimulated B cells from old mice, E47 is present to a lesser extent than in young mice, it increases after 24 and 48 h of stimulation, and it decreases slightly at 72 h. The fold increase in young vs old after LPS stimulation is 1.45 vs 1.44 at 24 h, 4.33 vs 1.69 at 48 h, and 0.6 vs 1.03 at 72 h. The levels of E47 expression were significantly higher in young than in old mice at all stimulation times. These results indicate that E47 DNA binding correlates with E47 protein expression (compare Fig. 3⇑B with Fig. 1⇑B). In Fig. 3⇑B, histone H-1 was used as loading control for the nuclear extracts, because histone H-1 is almost exclusively present in nuclear as opposed to cytoplasmic extracts in splenic B cells and is not modified by aging or stimulation (34). Again, ku 80 is also unaffected by aging and/or by LPS stimulation.

E12 is expressed at lower levels, as compared to E47, in LPS-stimulated splenic B cells from both young and old mice and is down-regulated by aging

To examine whether E12 is modulated by aging in splenic B cells, nuclear extracts from splenic B cells, LPS activated during a period of 48 h, were analyzed for E47 and E12 protein expression by Western analysis (Fig. 4⇓). Results show that, unlike E47, E12 appears to be present at very low levels in LPS-activated splenic B cells from young mice. Aging significantly impairs the expression of both proteins in nuclear extracts of LPS-activated splenic B cells.

FIGURE 4.
  • Download figure
  • Open in new tab
  • Download powerpoint
FIGURE 4.

Splenic B cells express predominantly E47 compared with E12. Splenic B cells (106 cells/ml) were stimulated with 10 μg/ml LPS for 48 h. Nuclear extracts from LPS-activated B cells from young and old mice were prepared and run in Western blot. The titration were 2, 4, and 8 μg of cell lysate/lane. E47, E12, and histone H-1 were detected with specific Abs. Films were scanned and analyzed as described in Fig. 1⇑B. Comparing the two lanes loaded with 8 μg/lane each, E12 was found to be 7- to 10-fold less expressed than E47 in LPS-activated B cells from young mice in three independent experiments.

Only nuclear extracts of splenic B cells, whereas both nuclear and cytoplasmic extracts of IL-7-expanded pro-B/pre-B cells exhibit DNA binding

We next addressed whether the different DNA binding of E47 seen in young and old mice may occur through different cellular compartmentalization of this E2A-encoded protein. To this purpose, nuclear and cytoplasmic extracts of LPS-activated splenic B cells as well as IL-7 blasts from both young and old mice were analyzed in EMSA and Western experiments. Results in Fig. 5⇓A indicate that only the nuclear extracts of unstimulated and LPS-activated splenic B cells from young mice exhibit DNA binding; this result correlates with Western data showing that nuclear extracts of LPS-activated splenic B cells exhibit higher expression of E47 than do cytoplasmic extracts (Fig. 5⇓B). In this experiment, cytoplasmic and nuclear extracts of B cells from young and old mice show comparable levels of β-actin. Although β-actin must be present at higher concentrations in the cytoplasm than in the nucleus, β-actin is found also in the nucleus, and the possible contamination of nuclear extracts is irrelevant to our conclusions, because cytoplasmic extracts of splenic B cells do not display DNA binding. B cells from old mice exhibited neither DNA-binding nor E47 expression in these experiments, but in other studies (see Fig. 1⇑C), some (four of eight) nuclear extracts from old mice were also able to show DNA binding. Conversely, in pro-B/pre-B cells, at least from young mice, both nuclear and cytoplasmic extracts display DNA binding and comparable levels of E47 (Fig. 6⇓). Because in almost all IL-7 nuclear and cytoplasmic extracts neither DNA binding nor expression by Western analysis could be seen for E47/E12, we were not able to determine whether both nuclear and cytoplasmic extracts had E47/E12.

FIGURE 5.
  • Download figure
  • Open in new tab
  • Download powerpoint
FIGURE 5.

LPS-stimulated splenic B cells show E47 expression and DNA binding only in the nucleus. A, Only nuclear extracts of LPS-stimulated splenic B cells from young mice exhibit DNA binding. In this particular experiment, old mice do not exhibit DNA binding either in nuclear (nu) or cytoplasmic (cy) extracts. Cytoplasmic and nuclear extracts of splenic B cells, unstimulated or stimulated with LPS for 48 h, were run in EMSA (10 μg/lane) in the presence (supershift) or absence of anti-E47 Abs. This experiment has been repeated three times, giving comparable results. NS, Nonspecific bands. B, In LPS-stimulated splenic B cells, E47 is expressed almost exclusively in the nucleus. Splenic B cells (106 cells/ml) were stimulated with 10 μg/ml LPS for 48 h. Cytoplasmic and nuclear extracts from LPS-activated B cells from young and old mice were prepared and run in Western blot. The titration was 2, 4, and 8 μg of cell lysate per lane. E47, β-actin, and histone H-1 were detected with specific Abs. Films were scanned and analyzed as described in Fig. 1⇑B. Comparing the two lanes loaded with 8 μg/lane each, E47 was found to be 10-fold less expressed in the cytoplasm than in the nucleus of LPS-activated B cells from young mice.

FIGURE 6.
  • Download figure
  • Open in new tab
  • Download powerpoint
FIGURE 6.

IL-7-expanded pro-B/pre-B cells show E47 and E12 expression and DNA binding in both the nucleus (nu) and cytoplasm (cy). A, Both nuclear and cytoplasmic extracts of IL-7-expanded pro-B/pre-B cells exhibit DNA binding. Cytoplasmic and nuclear extracts of IL-7-expanded pro-B/pre-B cells were run in EMSA (10 μg/lane) in the presence or absence of anti-E47 and anti-E12 Abs. This experiment has been repeated six times, giving comparable results. Anti-E47, anti-E12, supershift, described in Materials and Methods. B, Cytoplasmic and nuclear extracts of IL-7-expanded pro-B/pre-B cells were run in Western blot. The titration was 2, 4, and 8 μg of cell lysate per lane. E47, E12, and β-actin were detected with specific Abs (see Materials and Methods). Y, Young; O, old.

Discussion

Many studies have demonstrated that E2A-encoded proteins are required for proper B cell lymphopoiesis (1, 14). In the bone marrow, E47 and E12 have been shown to regulate the expression of several B cell genes required for pre-B cell receptor (BCR) and BCR expression and, consequently, control the progression from late pro-B to the Ig+ stage (15, 16, 17, 18, 19). In bone marrow precursor B cells and splenic mature B cells, E2A-encoded proteins have been shown to be involved in V(D)J recombination and in the promotion of Ig class switch recombination (2). In an experimental system in which E2A activity can be increased or suppressed in an inducible manner, E2A has been described to control cell cycle progression by increasing the expression of multiple cyclins, including D2 and D3 (39). E2A may also be involved in somatic mutation (U. Storb, personal communication, and 40). Here, we demonstrate that E2A activity, as induced by LPS in splenic B cells, is significantly lower in B cells derived from aged mice.

The effects of aging on murine B cell precursors in the bone marrow have been well characterized. The transition from the early pre-B (CD43+) cell stage to the late pre-B (CD43−) cell stage, which depends on the expression of the pre-BCR (μ/λ5/VpreB) (41, 42, 43), is significantly less efficient in aging (33). In vivo, CD43+B220+ pro-B/pre-B cells from old mice have reduced surface and cytoplasmic expression of λ5, as well as reduced λ5 mRNA (33). Also in vitro IL-7-expanded pro-B/pre-B cells from old mice show decreased expression of both λ5 and VpreB at the mRNA level, suggesting that the age-related reduction in surrogate light chains results, in part, from dysfunctional transcriptional regulation (26). A decrease in the expression of the E2A-encoded transcription factors E47 and/or E12 during aging correlates with a reduced expression of the λ5 component of the surrogate light chain and, in turn, with reduced pre-B cell numbers (26). Here we show that nuclear extracts of IL-7-stimulated pro-B/pre-B cells from old mice, exhibiting reduced amounts of E47 and E12 expression, also display reduced ability to bind DNA. The decrease in E47/E12 protein itself can explain the decrease in EMSA activity; we do not yet know about posttranslational modifications of these transcription factors. In these cells, Ikaros, a zinc finger transcription factor exerting a critical role during the early stages of B cell development, is unaffected by aging, demonstrating that not all proteins or transcription factors are down-regulated during aging.

Little is known concerning the effects of aging on E2A activity in mature B cells. This is the first study describing that the DNA binding of the E2A-encoded protein E47 is reduced in splenic B cells from old as compared with young mice. This reduction reflects decreased levels of E47 expression in the nuclear extracts of splenic B cells from old mice and likely contributes to the reduced B cell proliferation and/or class switch observed in aging mice (43, 44). It might also contribute to the age-related changes in the quality of the Ab response, because the expression of the Ab repertoire changes with age and shifts with respect to Ab specificity, affinity, and heterogeneity. Old mice produce reduced serum levels of Abs against exogenous Ags, these Abs being also of reduced affinity, and higher serum levels of autoantibodies (45, 46, 47). Moreover, the Abs produced in old mice are often oligoclonal (48). Several factors contribute to these changes including thymic involution and reduced T cell functions, which are critical for B cell development, somatic mutation, and isotype switching. It has not yet been well clarified whether B cells from old mice may function normally if adequate T cell help is provided. Nonetheless, several recent reports have shown intrinsic changes in the B cell pool affecting B cell responses. These include clonal expansion of CD5+ B cells (48, 49), impaired signal transduction events through the BCR (50), reduced inducibility of costimulatory molecules (30), and also reduced expression and activity of E2A-encoded transcription factors (herein). Moreover, it has been demonstrated that peripheral B cells from old mice are phenotypically distinct from those found in young mice and that these unique B cell populations arise and are maintained as a consequence of chronic antigenic stimulation (51). Even though we have shown that both bone marrow B cell precursors and mature splenic B cells have a decrease in E2A DNA binding, we do not think that the E2A-deficient splenic B cells are derived only from E2A-deficient recent immigrants from the bone marrow given that these would be only a small population of the total mature B cells we are analyzing in the B220-purified splenic cells (23, 52).

Data in the present paper confirm the observations (10, 11, 53) that in mature B cells E2A proteins bind DNA as E47/E47 complexes. This likely reflects the fact that E12 binds DNA poorly as a homodimer as a consequence of a negative domain immediately N-terminal to the bHLH motif (54, 55), as well as that E12 is expressed at lower levels than E47 in mature B cells (54). Thus, E2A proteins in B cells are unique in their ability to bind DNA as homodimers, whereas in the muscle, in the brain, or in pancreatic cells they bind DNA as heterodimers (10, 11, 54). As Benezra (56) has demonstrated in cell lines, this homodimer contains two disulfide-linked molecules of E47. It should be pointed out that, despite the large body of results on mature B cells, no evidence exists in the literature on the composition of the complex able to bind DNA in B cell precursors. The EMSA results in this paper demonstrate that in splenic mature B cells only E47/E47 complexes bind DNA, whereas in IL-7-expanded pro-B/pre-B cells E47/E12 complexes are involved in DNA binding, likely because splenic B cells express predominantly E47 whereas pro-B/pre-B cells express comparable levels of E47 and E12. In conclusion, the main findings of this study are: 1) the age-dependent decrease in the DNA binding of E12 and/or E47 in both bone marrow and spleen; 2) the different composition of the DNA-binding complexes in IL-7-expanded pro-B/pre-B cells, where both E47/E12 participate in DNA binding, and in the splenic B cells, where E47/E47 complexes bind DNA; and 3) the observation that both nuclear and cytoplasmic extracts of IL-7-expanded pro-B/pre-B cells, but only, nuclear extracts of LPS-activated splenic B cells, show E2A gene expression and DNA binding. These results provide insight into mechanisms through which aging affects B cell development in the bone marrow and B cell functions in the spleen via a down-regulation of the E12/E47 transcription factors and suggest possible approaches for augmenting the humoral response in aged individuals.

Acknowledgments

We thank U. Storb for permission to cite her unpublished work and review of the manuscript.

Footnotes

  • ↵1 This work was supported by National Institutes of Health Grants AG-17618 (to B.B.B.) and AG-15474 (to R.L.R.).

  • ↵2 Address correspondence and reprint requests to Dr. Bonnie B. Blomberg, Department of Microbiology and Immunology, RMSB, No. II 3146A, University of Miami School of Medicine, 1600 Northwest 10th Avenue, Miami, FL 33136. E-mail address: bblomber{at}med.miami.edu

  • ↵3 Abbreviations used in this paper: bHLH, basic helix-loop-helix; BCR, B cell receptor; VpreB, variable-like region of the pre-B cell receptor.

  • Received August 13, 2002.
  • Accepted November 8, 2002.
  • Copyright © 2003 by The American Association of Immunologists

References

  1. ↵
    Quong, M. W., W. J. Romanow, C. Murre. 2002. E protein function in lymphocyte development. Annu. Rev. Immunol. 20: 301
    OpenUrlCrossRefPubMed
  2. ↵
    Murre, C., P. S. McCaw, D. Baltimore. 1989. A new DNA binding and dimerization motif in immunoglobulin enhancer binding, daughterless, MyoD, and myc proteins. Cell 56: 777
    OpenUrlCrossRefPubMed
  3. ↵
    Quong, M. W., D. P. Harris, S. L. Swain, C. Murre. 1999. E2A activity is induced during B-cell activation to promote immunoglobulin class switch recombination. EMBO J. 18: 6307
    OpenUrlAbstract/FREE Full Text
  4. ↵
    Massari, M. E., P. A. Jennings, C. Murre. 1996. The AD1 transactivation domain of E2A contains a highly conserved helix which is required for its activity in both Saccharomyces cerevisiae and mammalian cells. Mol. Cell. Biol. 16: 121
    OpenUrlAbstract/FREE Full Text
  5. ↵
    Henthorn, P., M. Kiledjian, T. Kadesch. 1990. Two distinct transcription factors that bind the immunoglobulin enhancer μE5/κ2 motif. Science 247: 467
    OpenUrlAbstract/FREE Full Text
  6. ↵
    Nelson, C., L. P. Shen, A. Meister, E. Fodor, W. J. Rutter. 1990. Pan: a transcriptional regulator that binds chymotrypsin, insulin, and AP-4 enhancer motifs. Genes Dev. 4: 1035
    OpenUrlAbstract/FREE Full Text
  7. ↵
    Murre, C., A. Voronova, D. Baltimore. 1991. B-cell- and myocyte-specific E2-box-binding factors contain E12/E47-like subunits. Mol. Cell. Biol. 11: 1156
    OpenUrlAbstract/FREE Full Text
  8. ↵
    Sloan, S. R., C. P. Shen, R. McCarrick-Walmsley, T. Kadesh. 1996. Phosphorylation of E47 as a potential determinant of B-cell-specific activity. Mol. Cell. Biol. 16: 6900
    OpenUrlAbstract/FREE Full Text
  9. ↵
    Chu, C., D. S. Kohtz. 2001. Identification of the E2A gene products as regulatory targets of the G1 cyclin-dependent kinases. J. Biol. Chem. 276: 8524
    OpenUrlAbstract/FREE Full Text
  10. ↵
    Lassar, A. B., R. L. Davis, W. E. Wright, T. Kadesch, C. Murre, A. Voronova, D. Baltimore, H. Weintraub. 1991. Functional activity of myogenic HLH proteins requires hetero-oligomerization with E12/E47-like proteins in vivo. Cell 66: 305
    OpenUrlCrossRefPubMed
  11. ↵
    Lee, J. E., S. M. Hollenberg, L. Snider, D. L. Turner, N. Lipnick, H. Weintraub. 1995. Conversion of Xenopus ectoderm into neurons by NeuroD, a basic helix-loop-helix protein. Science 268: 836
    OpenUrlAbstract/FREE Full Text
  12. ↵
    Herblot, S., P. D. Aplan, T. Hoang. 2002. Gradient of E2A activity in B-cell development. Mol. Cell. Biol. 22: 886
    OpenUrlAbstract/FREE Full Text
  13. ↵
    Bain, G., E. C. Maandag, D. J. Izon, D. Amsen, A. M. Kruisbeek, B. C. Weintraub, I. Krop, M. S. Schlissel, A. J. Feeney, M. van Roon. 1994. E2A proteins are required for proper B cell development and initiation of immunoglobulin gene rearrangements. Cell 79: 885
    OpenUrlCrossRefPubMed
  14. ↵
    Zhuang, Y., P. Soriano, H. Weintraub. 1994. The helix-loop-helix gene E2A is required for B cell formation. Cell 79: 875
    OpenUrlCrossRefPubMed
  15. ↵
    Bain, G., E. C. Robanus Maandag, H. P. te Riele, A. J. Feeney, A. Sheehy, M. Schlissel, S. A. Shinton, R. R. Hardy, C. Murre. 1997. Both E12 and E47 allow commitment to the B cell lineage. Immunity 6: 145
    OpenUrlCrossRefPubMed
  16. ↵
    Schlissel, M., A. Voronova, D. Baltimore. 1991. Helix-loop-helix transcription factor E47 activates germ-line immunoglobulin heavy-chain gene transcription and rearrangement in a pre-T-cell line. Genes Dev. 5: 1376
    OpenUrl
  17. ↵
    Choi, J. K., C. P. Shen, H. S. Radomska, L. A. Eckhardt, T. Kadesch. 1996. E47 activates the Ig-heavy chain and TdT loci in non-B cells. EMBO J. 15: 5014
    OpenUrlPubMed
  18. ↵
    Sigvardsson, M., M. O’Riordan, R. Grosschedl. 1997. EBF and E47 collaborate to induce expression of the endogenous immunoglobulin surrogate light chain genes. Immunity 7: 25
    OpenUrlCrossRefPubMed
  19. ↵
    Kee, B. L., C. Murre. 1998. Induction of early B cell factor (EBF) and multiple B lineage genes by the basic helix-loop-helix transcription factor E12. J. Exp. Med. 188: 699
    OpenUrlAbstract/FREE Full Text
  20. ↵
    Romanow, W. J., A. W. Langerak, P. Goebel, I. L. Wolvers-Tettero, J. J. van Dongen, A. J. Feeney, C. Murre. 2000. E2A and EBF act in synergy with the V(D)J recombinase to generate a diverse immunoglobulin repertoire in nonlymphoid cells. Mol. Cell 5: 343
    OpenUrlCrossRefPubMed
  21. ↵
    Goebel, P., N. Janney, J. R. Valenzuela, W. J. Romanow, C. Murre, A. J. Feeney. 2001. Localized gene-specific induction of accessibility to V(D)J recombination induced by E2A and early B cell factor in nonlymphoid cells. J. Exp. Med. 194: 645
    OpenUrlAbstract/FREE Full Text
  22. ↵
    Riley, R. L., M. G. Kruger, J. Elia. 1991. B cell precursors are decreased in senescent BALB/c mice, but retain normal mitotic activity in vivo and in vitro. Clin. Immunol. Immunopathol. 59: 301
    OpenUrlCrossRefPubMed
  23. ↵
    Klinman, N. R., G. H. Kline. 1997. The B-cell biology of aging. Immunol. Rev. 160: 103
    OpenUrlCrossRefPubMed
  24. ↵
    Szabo, P., S. Shen, M. E. Weksler. 1999. Age-associated defects in B lymphocyte development. Exp. Gerontol. 34: 431
    OpenUrlCrossRefPubMed
  25. ↵
    Weksler, M. E., P. Szabo. 2000. The effect of age on the B-cell repertoire. J. Clin. Immunol. 20: 240
    OpenUrlCrossRefPubMed
  26. ↵
    Sherwood, E. M., W. Xu, A. M. King, B. B. Blomberg, R. L. Riley. 2000. The reduced expression of surrogate light chains in B cell precursors from senescent BALB/c mice is associated with decreased E2A proteins. Mech. Ageing Dev. 118: 45
    OpenUrlCrossRefPubMed
  27. ↵
    Li, F., F. Jin, A. Freitas, P. Szabo, M. E. Weksler. 2001. Impaired regeneration of the peripheral B cell repertoire from bone marrow following lymphopenia in old mice. Eur. J. Immunol. 31: 500
    OpenUrlCrossRefPubMed
  28. ↵
    Kline, G. H., T. A. Hayden, N. R. Klinman. 1999. B cell maintenance in aged mice reflects both increased B cell longevity and decreased B cell generation. J. Immunol. 162: 3342
    OpenUrlAbstract/FREE Full Text
  29. ↵
    Zheng, B., S. Han, Y. Takahashi, G. Kelsoe. 1997. Immunosenescence and germinal center reaction. Immunol. Rev. 160: 63
    OpenUrlCrossRefPubMed
  30. ↵
    Berek, G., A. Berger, M. Apel. 1991. Mutation of the immune response in germinal centers. Cell 67: 1121
    OpenUrlCrossRefPubMed
  31. ↵
    Jacob, J., G. Kelsoe, K. Rajewsky, U. Weiss. 1991. Intraclonal generation of antibody mutants in germinal centers. Nature 354: 389
    OpenUrlCrossRefPubMed
  32. ↵
    Lui, Y. J., F. Malisan, O. de Bouteiller, C. Guret, S. Lebecque, J. Banchereau, F. C. Mills, E. E. Max, H. Martinez-Valdez. 1996. Within germinal centers, isotype switching of immunoglobulin genes occurs after the onset of somatic mutation. Immunity 4: 241
    OpenUrlCrossRefPubMed
  33. ↵
    Sherwood, E. M., B. B. Blomberg, W. Xu, C. A. Warner, R. L. Riley. 1998. Senescent BALB/c mice exhibit decreased expression of λ5 surrogate light chains and reduced development within the pre-B cell compartment. J. Immunol. 161: 4472
    OpenUrlAbstract/FREE Full Text
  34. ↵
    Frasca, D., D. Nguyen, R. L. Riley, and B. B. Blomberg. Effects of aging on proliferation and E47 transcription factor activity inducedby different stimuli in murine splenic B cells. Mech. Ageing Dev. In press.
  35. ↵
    Jacobs, Y., C. Vierra, C. Nelson. 1993. E2A expression, nuclear localization, and in vivo formation of DNA- and non-DNA-binding species during B-cell development. Mol. Cell. Biol. 13: 7321
    OpenUrlAbstract/FREE Full Text
  36. ↵
    Bain, G., C. L. Cravatt, C. Loomans, J. Alberola-Ila, S. M. Hedrick, C. Murre. 2001. Regulation of the helix-loop-helix proteins, E2A and Id3, by the Ras-ERK MAPK cascade. Nat. Immunol. 2: 165
    OpenUrlCrossRefPubMed
  37. ↵
    Yaneva, M., T. Kowalewski, M. R. Lieber. 1997. Interaction of DNA-dependent protein kinase with DNA and with Ku: biochemical and atomic-force microscopy studies. EMBO J. 16: 5098
    OpenUrlAbstract
  38. ↵
    Frasca, D., B. Barattini, G. Tocchi, L. Guidi, L. Pierelli, G. Doria. 2001. Role of DNA-dependent protein kinase in recognition of radiation-induced DNA damage in human peripheral blood mononuclear cells. Int. Immunol. 13: 791
    OpenUrlAbstract/FREE Full Text
  39. ↵
    Zhao, F., A. Vilardi, R. J. Neely, J. C. Choi. 2001. Promotion of cell cycle progression by basic helix-loop-helix E2A. Mol. Cell. Biol. 21: 6346
    OpenUrlAbstract/FREE Full Text
  40. ↵
    Storb, U., N. Michael, N. Kim, H. Nguyen, and T. E. Martin. 2001. Molecular basis of somatic hyper mutation of immunoglobulin genes. In Keystone Symposia on B Lymphocytes, Snowbird, UT, April 17–22 (Abstr.).
  41. ↵
    Kitamura, D., J. Roes, R. Kuhn, K. Rajewsky. 1991. A B cell-deficient mouse by targeted disruption of the membrane exon of the immunoglobulin mu chain gene. Nature 350: 423
    OpenUrlCrossRefPubMed
  42. ↵
    Kitamura, D., A. Kudo, S. Schaal, W. Muller, F. Melchers, K. Rajewsky. 1992. A critical role of protein in cell development. Cell 69: 823
    OpenUrlCrossRefPubMed
  43. ↵
    Rolink, A., U. Grawunder, T. H. Winkler, H. Karasuyama, F. Melchers. 1994. IL-2 receptor α chain (CD25, TAC) expression defines a crucial stage in pre-B cell development. Int. Immunol. 6: 1257
    OpenUrlAbstract/FREE Full Text
  44. ↵
    Williams, G. T., C. J. Jolly, J. Köhler, M. S. Neuberger. 2000. The contribution of somatic hypermutation to the diversity of serum immunoglobulin: dramatic increase with age. Immunity 13: 409
    OpenUrlCrossRefPubMed
  45. ↵
    Bovbjerg, B. J., Y. T. Kim, R. Schwab, K. Schmitt, T. De Blasio, M. E. Weksler. 1991. Cross-wiring of the immune response in old mice: increased autoantibody response despite reduced antibody response to nominal antigens. Cell. Immunol. 135: 519
    OpenUrlCrossRefPubMed
  46. ↵
    Klinman, N. R.. 1992. Similarities in B cell repertoire development between autoimmune and aging normal mice. J. Immunol. 148: 1353
    OpenUrlAbstract
  47. ↵
    Zhao, K. S., Y. F. Wang, R. Gueret, M. E. Weksler. 1995. Dysregulation of the humoral immune response in old mice. Int. Immunol. 7: 929
    OpenUrlAbstract/FREE Full Text
  48. ↵
    Ben-Yehuda, A., P. Szabo, J. LeMaoult, J. S. Manavalan, M. E. Weksler. 1998. Increased VH 11 and VH Q52 gene use by splenic B cells in old mice associated with oligoclonal expansions of CD5+B cells. Mech. Ageing Dev. 103: 111
    OpenUrlCrossRefPubMed
  49. ↵
    Hu, A., D. Ehleiter, A. Ben-Yehuda, R. Schwab, C. Russo, P. Szabo, M. E. Weksler. 1993. Effect of age on the expressed B cell repertoire: role of B cell subsets. Int. Immunol. 5: 1035
    OpenUrlAbstract/FREE Full Text
  50. ↵
    Whisler, R. L., Y. G. Newhouse, I. S. Grants, K. V. Hackshaw. 1995. Differential expression of the α and β isoforms of protein kinase C in peripheral blood T and B cells from young and elderly adults. Mech. Ageing Dev. 77: 197
    OpenUrlCrossRefPubMed
  51. ↵
    Johnson, S. A., S. J. Rozzo, J. C. Cambier. 2002. Aging-dependent exclusion of antigen-inexperienced cells from the peripheral B cell repertoire. J. Immunol. 168: 5014
    OpenUrlAbstract/FREE Full Text
  52. ↵
    Kline, G. H., T. A. Hayden, N. R. Klinman. 1999. B cell maintenance in aged mice reflects both increased B cell longevity and decreased B cell generation. J. Immunol. 162: 3342
    OpenUrlAbstract/FREE Full Text
  53. ↵
    Aronheim, A., H. Ohlsson, C. W. Park, T. Edlund, M. D. Walker. 1991. Distribution and characterization of helix-loop-helix enhancer-binding proteins from pancreatic β cells and lymphocytes. Nucleic Acids Res. 19: 3893
    OpenUrlAbstract/FREE Full Text
  54. ↵
    Shen, C. P., T. Kadesch. 1995. B-cell-specific DNA binding by an E47 homodimer. Mol. Cell. Biol. 15: 4518
    OpenUrlAbstract/FREE Full Text
  55. ↵
    Sun, X. H., D. Baltimore. 1991. An inhibitory domain of E12 transcription factor prevents DNA binding in E12 homodimers but not in E12 heterodimers. [Published erratum appears in 1991 Cell 66:423]. Cell 64: 459
    OpenUrlCrossRefPubMed
  56. ↵
    Benezra, R.. 1994. An intermolecular disulfide bond stabilizes E2A homodimers and is required for DNA binding at physiological temperatures. Cell 79: 1057
    OpenUrlCrossRefPubMed
PreviousNext
Back to top

In this issue

The Journal of Immunology: 170 (2)
The Journal of Immunology
Vol. 170, Issue 2
15 Jan 2003
  • Table of Contents
  • About the Cover
Print
Download PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for your interest in spreading the word about The Journal of Immunology.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
Decreased E12 and/or E47 Transcription Factor Activity in the Bone Marrow As Well As in the Spleen of Aged Mice
(Your Name) has forwarded a page to you from The Journal of Immunology
(Your Name) thought you would like to see this page from the The Journal of Immunology web site.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Citation Tools
Decreased E12 and/or E47 Transcription Factor Activity in the Bone Marrow As Well As in the Spleen of Aged Mice
Daniela Frasca, Diep Nguyen, Richard L. Riley, Bonnie B. Blomberg
The Journal of Immunology January 15, 2003, 170 (2) 719-726; DOI: 10.4049/jimmunol.170.2.719

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Share
Decreased E12 and/or E47 Transcription Factor Activity in the Bone Marrow As Well As in the Spleen of Aged Mice
Daniela Frasca, Diep Nguyen, Richard L. Riley, Bonnie B. Blomberg
The Journal of Immunology January 15, 2003, 170 (2) 719-726; DOI: 10.4049/jimmunol.170.2.719
del.icio.us logo Digg logo Reddit logo Twitter logo CiteULike logo Facebook logo Google logo Mendeley logo
  • Tweet Widget
  • Facebook Like

Jump to section

  • Article
    • Abstract
    • Materials and Methods
    • Results
    • Discussion
    • Acknowledgments
    • Footnotes
    • References
  • Figures & Data
  • Info & Metrics
  • PDF

Related Articles

Cited By...

More in this TOC Section

  • Innate Immunity Together with Duration of Antigen Persistence Regulate Effector T Cell Induction
  • Regulatory Roles of IL-2 and IL-4 in H4/Inducible Costimulator Expression on Activated CD4+ T Cells During Th Cell Development
  • Induction of CD4+ T Cell Apoptosis as a Consequence of Impaired Cytoskeletal Rearrangement in UVB-Irradiated Dendritic Cells
Show more CELLULAR IMMUNOLOGY AND IMMUNE REGULATION

Similar Articles

Navigate

  • Home
  • Current Issue
  • Next in The JI
  • Archive
  • Brief Reviews
  • Pillars of Immunology
  • Translating Immunology

For Authors

  • Submit a Manuscript
  • Instructions for Authors
  • About the Journal
  • Journal Policies
  • Editors

General Information

  • Advertisers
  • Subscribers
  • Rights and Permissions
  • Accessibility Statement
  • FAR 889
  • Privacy Policy
  • Disclaimer

Journal Services

  • Email Alerts
  • RSS Feeds
  • ImmunoCasts
  • Twitter

Copyright © 2021 by The American Association of Immunologists, Inc.

Print ISSN 0022-1767        Online ISSN 1550-6606